Source: Annual Congress 2004 - Biological correlates of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. E. Valevich, A. E. Makarevich (Minsk, Belarus). The conjunctival microcirculation disturbances at COPD patients in combination with diabetes mellitus type 2 and their correction by gliclazide. Eur Respir J 2004; 24: Suppl. 48, 500

Member's Comments

No comment yet.

Related content which might interest you: Comparison of COPD patients with and without diabetes mellitus Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control Source: Annual Congress 2008 - COPD and comorbidities Year: 2008 Study of PFT‘s in patients with type 2 diabetes mellitus and diabetic neuropathy and microangiopathy Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases Year: 2007 A study of the comorbidity of COPD and type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Metformin predispose acute exacerbations of COPD patients with insulin-dependent diabetes mellitus> Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Development of diabetes mellitus in patients with bronchial asthma Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008 Relative risk of type 2 diabetes mellitus complications is increased in non effectively treated OSA patients Source: Eur Respir J 2005; 26: Suppl. 49, 39s Year: 2005 Study of pulmonary function in type2 diabetes mellitus and its changes with change in duration and glycemic control Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights Year: 2012 Safety profile of COPD medications in COPD patients with concomitant diabetes mellitus Source: International Congress 2017 – COPD management Year: 2017 Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2? Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities Year: 2009 Risk of development of diabetes mellitus in patients with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 323s Year: 2006 Control of ventilation in patients with insulin-dependent diabetes mellitus complicated by autonomic neuropathy Source: Eur Respir J 2005; 26: Suppl. 49, 66s Year: 2005 The association of pulmonary fibrosis with diabetes mellitus Source: ERJ Open Res, 6 (4) 00237-2020; 10.1183/23120541.00237-2020 Year: 2020 Measurment of lung diffusion capacity in patients with diabetes mellitus Source: Annual Congress 2009 - Impact on respiratory function of pulmonary and extrapulmonary diseases Year: 2009 Study of the connection between COPD, bronchial asthma and diabetes mellitus types 1 and 2 Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009 Inhaled insulin does not induce immediate airway responsiveness in patients with type 1 diabetes mellitus Source: Eur Respir J 2005; 26: Suppl. 49, 582s Year: 2005 The evaluation of systemic inflammation in COPD patients comorbided with cardiovascular diseases or diabetes mellitus Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Are spirometry indices associated with microvascular complications in type 1 diabetes subjects? Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019 Effect of roflumilast (ROF) on glucose levels in patients with COPD and diabetes mellitus type 2 (DM2) Source: Annual Congress 2010 - COPD: management Year: 2010